This Week in Managed Care—Stakeholders Weigh in on Drug Pricing Plan and Other Health News

Managed Care Cast

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care stories included patient advocates, providers, payers, and pharma commenting on the Trump administration's drug pricing plan; a survey that found physicians and payers believe progress toward value-based care is slowing; a study that questions the standards of evidence for breakthrough therapy approvals. Read more about the stories in this podcast: From Patient Advocates to Pharma, Groups Weigh in on Trump Blueprint for Drug Costs: https://www.ajmc.com/newsroom/from-patient-advocates-to-pharma-groups-weigh-in-on-trump-blueprint-for-drug-costs Novartis Will Freeze Drug Prices Through End of 2018, CEO Says: https://www.ajmc.com/newsroom/novartis-will-freeze-drug-prices-through-end-of-2018-ceo-says What We're Reading: 340B Lawsuit to Be Refiled; Digging Into Breakthrough Approvals; Screen Time and ADHD: https://www.ajmc.com/newsroom/what-were-reading-340b-lawsuit-to-be-refiled-digging-into-breakthrough-approvals-screen-time-and-adhd Pause in Risk Adjustment Payments Announced, CMS Blames District Court's Decision: https://www.ajmc.com/newsroom/pause-in-risk-adjustment-payments-announced-cms-blames-district-courts-decision Doctors, Payers Think Transition to Value-Based Care Has Slowed, Survey Says: https://www.ajmc.com/newsroom/doctors-payers-think-transition-to-valuebased-care-has-slowed-survey-says Do Breakthrough Therapies Need More Rigorous Evaluation? https://www.ajmc.com/newsroom/do-breakthrough-therapies-need-more-rigorous-evaluation- Evidence-Based Oncology - July 2018: https://www.ajmc.com/journals/evidence-based-oncology/2018/july-2018